Epigenetic Downregulation of Hsa-miR-193b-3p Increases Cyclin D1 Expression Level and Cell Proliferation in Human Meningiomas.
DNA methylation
cyclin D1
epigenetics
hsa-miR-193b-3p
meningioma
microRNA
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
30 Aug 2023
30 Aug 2023
Historique:
received:
20
07
2023
revised:
21
08
2023
accepted:
24
08
2023
medline:
11
9
2023
pubmed:
9
9
2023
entrez:
9
9
2023
Statut:
epublish
Résumé
Meningiomas are common intracranial tumors in adults. Abnormal microRNA (miRNA) expression plays a role in their pathogenesis. Change in miRNA expression level can be caused by impaired epigenetic regulation of miRNA-encoding genes. We found the genomic region covering the
Identifiants
pubmed: 37686289
pii: ijms241713483
doi: 10.3390/ijms241713483
pmc: PMC10487813
pii:
doi:
Substances chimiques
Cyclin D1
136601-57-5
MicroRNAs
0
MIRN193 microRNA, human
0
CCND1 protein, human
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : National Science Center
ID : 2018/29/B/NZ5/02035
Références
J Neurosci Res. 2014 May;92(5):619-26
pubmed: 24496888
Cancer Med. 2015 Sep;4(9):1417-25
pubmed: 26129688
Oncogene. 2009 Nov 5;28(44):3926-36
pubmed: 19684618
Dev Biol. 2007 Feb 1;302(1):1-12
pubmed: 16989803
J Cell Physiol. 2019 Aug;234(10):16861-16872
pubmed: 30779342
Neurosurg Rev. 2020 Jun;43(3):903-910
pubmed: 30788677
Int J Oncol. 1996 Dec;9(6):1213-7
pubmed: 21541630
Acta Histochem. 2016 May;118(4):323-30
pubmed: 27071318
Neurology. 2004 Apr 13;62(7):1210-2
pubmed: 15079029
Cancers (Basel). 2016 Mar 03;8(3):
pubmed: 26950155
J Neurooncol. 2016 Dec;130(3):473-484
pubmed: 27614886
Cells. 2020 Dec 09;9(12):
pubmed: 33317149
Acta Neuropathol. 2017 Mar;133(3):431-444
pubmed: 28130639
Science. 2019 Dec 20;366(6472):
pubmed: 31806698
Int J Cancer. 2010 Sep 1;127(6):1363-72
pubmed: 20073067
PLoS One. 2015 Apr 23;10(4):e0125515
pubmed: 25905463
Brain Pathol. 2010 May;20(3):623-31
pubmed: 19922547
Neurosurg Focus. 2013 Dec;35(6):E5
pubmed: 24289130
Mol Cancer Res. 2012 Feb;10(2):259-69
pubmed: 22188669
Rev Neurosci. 2020 Oct 25;31(7):771-778
pubmed: 32697762
Front Pharmacol. 2019 Feb 22;10:134
pubmed: 30853911
BMC Cancer. 2022 Apr 7;22(1):367
pubmed: 35392834
J Clin Neurosci. 2007 Apr;14(4):355-8
pubmed: 17240151
Genes (Basel). 2023 Jun 29;14(7):
pubmed: 37510280
J Cell Biochem. 2017 Jun;118(6):1563-1573
pubmed: 27918099
Bioinformatics. 2012 Nov 15;28(22):2986-8
pubmed: 22954632
Cancer Res. 1986 Aug;46(8 Suppl):4244s-4248s
pubmed: 3524805
Mol Oncol. 2019 Sep;13(9):1944-1958
pubmed: 31225930
Front Oncol. 2022 Jul 22;12:931371
pubmed: 35936751
Lancet Oncol. 2017 May;18(5):682-694
pubmed: 28314689
Signal Transduct Target Ther. 2016 Jan 28;1:15004
pubmed: 29263891
Mol Med Rep. 2016 Jul;14(1):283-8
pubmed: 27176876
Neurooncol Pract. 2022 Feb 22;9(3):165-182
pubmed: 35601966
Genes (Basel). 2023 May 12;14(5):
pubmed: 37239435
Cancer Res. 2017 Nov 1;77(21):5728-5740
pubmed: 28882999
Eur J Cancer. 2010 Oct;46(15):2828-36
pubmed: 20655737
Med Oncol. 2015 Jan;32(1):439
pubmed: 25502086
Cell Mol Neurobiol. 2008 Sep;28(6):907-13
pubmed: 18379871
Oncol Lett. 2017 Apr;13(4):2557-2562
pubmed: 28454433
Bioinformatics. 2017 Feb 15;33(4):558-560
pubmed: 28035024
Acta Biochim Biophys Sin (Shanghai). 2012 May;44(5):424-30
pubmed: 22491710
Breast Cancer. 2019 Mar;26(2):215-228
pubmed: 30284194
Acta Neuropathol. 2023 Jul;146(1):145-162
pubmed: 37093270
Am J Pathol. 2010 May;176(5):2520-9
pubmed: 20304954
Biomol Concepts. 2017 Dec 20;8(5-6):203-212
pubmed: 29161231
J Neurooncol. 2022 Jan;156(2):205-214
pubmed: 34846640
Nat Commun. 2019 Dec 11;10(1):5657
pubmed: 31827083